On September 25, ASHG hosted a virtual Forum with several members of the International Commission on the Clinical Use of Human Germline Genome Editing. The Forum was chaired by Charles Rotimi of NIH, and speakers shared findings from the Commission’s final report on Heritable Human Genome Editing (HHGE), which was released earlier that month. The... Read More
Published: Wednesday, October 7, 2020, 11:00 a.m. U.S. Eastern Time Media Contact: Kara Flynn, 202.257.8424, press@ashg.org ROCKVILLE, MD – The American Society of Human Genetics (ASHG) applauds and congratulates geneticists Emmanuelle Charpentier, PhD, of the Max Planck Unit for the Science of Pathogens, and Jennifer Doudna, PhD, of the University of California, Berkeley, on their honor... Read More
For Immediate Release Monday, November 26, 2018 1:30 p.m. U.S. Pacific Time Media Contact: Nalini Padmanabhan 301.634.7346 press@ashg.org Report from China, if Confirmed, Would Be at Odds with Field Consensus that Germline Editing is Not Ready for Human Use ROCKVILLE, Md. – Given this morning’s reports of infants possibly born in China whose genomes were... Read More
For Immediate Release Thursday, August 3, 2017 12:00 p.m. U.S. Eastern Time Media Contact: Nalini Padmanabhan ASHG Communications Manager 301.634.7346 press@ashg.org Medical, Research, and Counseling Groups Issue Statement on Germline Genome Editing BETHESDA, MD – An international group of 11 organizations with genetics expertise has issued a policy statement on germline genome editing in humans,... Read More
I am delighted to announce that ASHG’s statement on germline genome editing was published today in The American Journal of Human Genetics. This statement, written by a workgroup co-led by Kelly Ormond and Doug Mortlock and approved by ASHG’s Board of Directors, gives the Society’s perspective on the use of CRISPR/Cas9 or other similar tools... Read More